Clinical Characteristics and Course of Patients Entering Cardiac Rehabilitation with Chronic Kidney Disease: Data from the Italian Survey on Cardiac Rehabilitation

Table 5

Drug therapy at hospital discharge after cardiac rehabilitation programs.

	CKD (𝑛=200)	Non-CKD (𝑛=2081)	𝑃 value
Inhibitors of angiotensin-converting enzyme	86 (43.0)	1171 (56.3)	0.0003
Angiotensin II receptor blockers	46 (23.0)	341 (16.4)	0.02
Beta-blockers	133 (66.5)	1433 (68.9)	0.49
Nitrates	68 (34.0)	372 (17.9)	<0.0001
Diuretics	156 (78.0)	1012 (48.6)	<0.0001
Statins	119 (59.5)	1391 (66.8)	0.03
Omega-3 fatty acids	26 (13.0)	352 (16.9)	0.15
Oral anticoagulant therapy	72 (36.0)	532 (25.6)	0.001
Aspirin	100 (50.0)	1408 (67.7)	<0.0001
Digitalis	23 (11.5)	101 (4.8)	<0.0001
Amiodarone	25 (12.5)	107 (5.1)	<0.0001
Calcium channel blockers	51 (25.5)	385 (18.5)	0.01
Antidepressant	21 (10.5)	120 (5.8)	0.008